Article

The Opening Great Debate: Ix and Health 2.0 - Synergies or Tensions?

This debate featured Don Kemper, CEO of Healthwise, and Matthew Holt, co-founder of Health 2.0, LLC, discussing information therapy and Health 2.0, and why they thought one was better than the other.

This debate featured Don Kemper, CEO of Healthwise, and Matthew Holt, co-founder of Health 2.0, LLC, discussing information therapy (Ix) and Health 2.0, and why they thought one was better than the other. Holt’s main concern was who is leading the Ix process? Physicians? Consumers? Other healthcare organizations?

Alan Greene, MD, founder of DrGreene.com, CMO of A.D.A.M., opined that patients need to start taking responsibility themselves and that doctors should provide the necessary information so the patients can understand their treatment.

It was interesting to hear Greene say that the stereotype of patients coming into appointments with medical information printed off the Internet is no longer the case according to discussions he’s had with fellow doctors. He said, “Patients are coming in with information from other patients online.”

DiabetesMine.com blogger Amy Tenderich commented that it’s all about learning; that patients either learn on their own or learn from their medical team. She said that Health 2.0 can survive on its own because of “self-motivated patients,” however there is a large number of patients who are unaware of how much important information is easily accessible. Tenderich said that evidence-based information comes from doctors, but everyday information comes from Health 2.0. She believes that Ix can’t survive on its own, while Health 2.0 can.

The ultimate question is “Why wouldn’t we want both?” Greene said, “We want the best of both worlds for the consumer.”

Do you think Ix or Health 2.0 is the way to go? Can they co-exist?

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Christine Frissora, MD | Credit: Weill Cornell
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
© 2024 MJH Life Sciences

All rights reserved.